“anemia” Archives

in
Entry Author Date Location
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH 01/28/20 Boston
Apellis Rare Blood Disease Drug Tops Alexion’s in Head-to-Head Test 01/07/20 Boston
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval 11/08/19 New York
Disc Medicine Launches With $50M to Advance New Anemia Treatments 10/29/19 Boston
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Celgene Files for FDA Approval of Blood Disease Drug 04/05/19 New York
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
With New Results, FibroGen’s Anemia Pill Inches Closer to FDA Review 12/20/18 San Francisco
Acceleron, Celgene Drug Shines in Phase 3 Test in Rare Blood Disorder 07/09/18 Boston
Akebia Merges With Keryx as Anemia Drug Race Nears Finish Line 06/28/18 Boston
For Sickle Cell, a Complex Disease, New Drugs Could Bring Complex Costs 06/15/18 San Francisco
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits 01/30/17 San Francisco
Akebia Gets $265M From Otsuka to Bankroll Anemia Drug Push 12/20/16 Boston
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
Bay Area Researchers Take A CRISPR Cut At Sickle Cell Disease 10/12/16 San Francisco
Roundup: Owlchemy, TheWaveVR, Fe3 Medical, & Rackspace Buyout? 08/09/16 Texas
Texas Government Adds $3.5M to Fe3 Series B for Anemia Treatment 08/08/16 Texas
After Rival Stumbles, Relypsa Gets $1.5B Buyout Bid From Galenica 07/21/16 San Francisco
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another 06/11/16 Boston
East Coast Biotech Roundup: Celldex, Ensemble, CRISPR Battle & More 03/10/16 Boston
InCube Labs Startup Fe3 Plans Iron-Delivering Patch For Anemia 03/04/16 Texas
With New Data, Highs and Lows For Akebia, Flexion, Tetraphase 09/08/15 Boston
Global Blood Thera Nabs $120M IPO, Doubles Share Price On First Day 08/11/15 San Francisco
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
Page 1 of 3 next page »